Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial
J. Clin. Oncol 2022 Dec 13;[EPub Ahead of Print], T Yau, V Zagonel, A Santoro, M Acosta-Rivera, SP Choo, A Matilla, AR He, A Cubillo Gracian, AB El-Khoueiry, B Sangro, TE Eldawy, J Bruix, GL Frassineti, GM Vaccaro, M Tschaika, C Scheffold, P Koopmans, J Neely, F PiscagliaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.